The Albany Glomerulonephritis Registry is a prospective cohort study that longitudinally collects disease-specific, treatment, and outcome data on patients with vasculitis and glomerular disease. All patients treated at the New York Vasculitis and Glomerular Center will be offered enrollment. Combining data from the Albany Glomerulonephritis Registry with other national registries will allow for a rigorous analysis of these rare diseases.
Clinical Trials(Coming soon)
1. Muhsin SA, Masia R, Smith RN, Wallace ZS, Perugino CA, Stone JH, Niles JL, Cortazar FB. Phospholipase A2 receptor-associated membranous nephropathy in a patient with IgG4-related disease: A case report. Medicine (Baltimore). 2019
2. Cortazar FB, Rosenthal J, Laliberte K, Niles JL. Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome. Clin Kidney J. 2018 Jul 24;12(2):224-231.
3. Zonozi R, Niles JL, Cortazar FB. Renal involvement in antineutrophil cytoplasmic antibody-associated vasculitis. Rheum Dis Clin North Am. 2018. Nov;44(4):525-543.
4. Cortazar FB, Muhsin SA, Pendergraft WF, Wallace ZS, Dunbar C, Laliberte K, Niles JL. Combination Therapy with Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis. Kidney Int Rep. 2018 Mar; 3(2):394-402.
5. Cortazar FB, Pendergraft WF, Wenger J, Owens CT, Laliberte K, Niles JL. Effect of Continuous B Cell Depletion with Rituximab on Pathogenic Autoantibodies and Total IgG Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2017 05; 69(5):1045-1053.
6. Cortazar FB, Leaf DE, Owens CT, Laliberte K, Pendergraft WF, Niles JL. Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series. BMC Nephrol. 2017 Feb 01; 18(1):44.
7. Cortazar FB, Stone JH. IgG4-related disease and the kidney. Nat Rev Nephrol. 2015 Oct; 11(10):599-609.
8. Pendergraft WF 3rd, Cortazar FB, Wenger J, Murphy AP, Rhee EP, Laliberte KA, Niles JL. Long-term maintenance therapy using rituximab-induced continuous B-cell depletion in patients with ANCA vasculitis. Clin J Am Soc Nephrol. 2014 Apr;9(4):736-44.